Potential additional benefits of glucagon-like peptide-1 receptor agonists in psoriasis

Journal Article Accepted manuscript Potential additional benefits of glucagon-like peptide-1 receptor agonists in psoriasis Get access Axel Svedbom Axel Svedbom Department of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden Email:[email protected] https://orcid.org/0000-0002-3916-9343 Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, ljaf382, https://doi.org/10.1093/bjd/ljaf382 Published: 01 October 2025 Article history Received: 23 September 2025 Accepted: 24 September 2025 Published: 01 October 2025